PainReform Ltd. Issues Year-End Business Update

Ticker: PRFX · Form: 6-K · Filed: Mar 1, 2024 · CIK: 1801834

Painreform Ltd. 6-K Filing Summary
FieldDetail
CompanyPainreform Ltd. (PRFX)
Form Type6-K
Filed DateMar 1, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: business-update, press-release, foreign-private-issuer

TL;DR

PainReform dropped a year-end update on March 1st, check the exhibits for deets.

AI Summary

On March 1, 2024, PainReform Ltd. issued a press release providing a year-end business update. The filing incorporates this press release as Exhibit 99.1. The company is a foreign private issuer and files annual reports under Form 20-F.

Why It Matters

This filing provides a routine update on the company's business activities as of the end of the year, which is important for investors to stay informed about the company's progress.

Risk Assessment

Risk Level: low — This is a routine 6-K filing providing a press release, with no new financial data or significant corporate actions disclosed.

Key Players & Entities

  • PainReform Ltd. (company) — Registrant
  • March 1, 2024 (date) — Date of press release and filing
  • Exhibit 99.1 (document) — Incorporated press release

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report a press release issued by PainReform Ltd. on March 1, 2024, titled 'PainReform Provides Year-End Business Update'.

What is the filing date of this report?

The filing date of this report is March 1, 2024.

What exhibit is included with this filing?

Exhibit 99.1, a press release dated March 1, 2024, is included with this filing.

Does PainReform Ltd. file annual reports under Form 20-F or 40-F?

PainReform Ltd. files annual reports under Form 20-F.

What is the principal executive office address of PainReform Ltd.?

The principal executive offices of PainReform Ltd. are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.

Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-03-01 08:09:46

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 1, 2024 PAINREFORM LTD. By: /s/ Ilan Hadar Ilan Hadar Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.